Indications, prognosis, and complications of de novo implantable cardioverter defibrillators in patients with type 2 diabetes and without diabetes

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Miss Yiran Zhou

Stockholm (Sweden)

9 More presentations in this session

Presentation thumbnail

Discussant - Ventricular arrhythmias

Presentation thumbnail

Influence of minimized atrial pacing on risk of ventricular arrhythmias in patients with pacemakers due to sinus node dysfunction

Mr F. Mikkelsen (Risskov, DK)

Presentation thumbnail

Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status

Miss Y. Zhou (Stockholm, SE)

Presentation thumbnail

Wearable cardioverter-defibrillator compared to beta blockers in patients at risk of sudden death: a real-world propensity score-matched study.

Professor L. Fauchier (Tours, FR)

Presentation thumbnail

Prognostic comparison between implantable cardioverter-defibrillator and amiodarone in cancer patients

Mr H. Kida (Osaka, JP)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Ventricular arrhythmias

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status

Congress Presentation

Indications for de novo pacemaker implantation, prognosis and complications in patients with and without type 2 diabetes mellitus.

Congress Session

'Shocking' news on implantable cardioverter defibrillators

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources